Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.(BBIO) | 6,068,125 | 6,068,125 | 0 | $153.71M | $154.49M | 59.18% | +$788.9K |
| Verona Pharma plc (VRNA)ADS | 1,115,352 | 1,115,352 | 0 | $16.13M | $32.09M | 12.29% | +$15.96M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,025,000 | 1,025,000 | 0 | $21.04M | $19.73M | 7.56% | -$1.31M |
| Bicara Therapeutics Inc. (BCAX) | 0 | 568,919 | +568,919 | $0 | $14.49M | 5.55% | +$14.49M |
| Biomea Fusion, Inc.(BMEA) | 798,757 | 798,757 | 0 | $3.59M | $8.07M | 3.09% | +$4.47M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,472,331 | 1,472,331 | 0 | $5.51M | $7.80M | 2.99% | +$2.30M |
| COMPASS Pathways plcADS(CMPS) | 964,500 | 964,500 | 0 | $5.83M | $6.08M | 2.33% | +$250.8K |
| Nuvation Bio Inc.CL A(NUVB) | 2,541,009 | 2,541,009 | 0 | $7.42M | $5.82M | 2.23% | -$1.60M |
| Poseida Therapeutics Inc. (PSTX) | 1,043,267 | 1,043,267 | 0 | $3.05M | $2.98M | 1.14% | -$62.6K |
| Tectonic Therapeutic, Inc.(TECX) | 84,148 | 84,148 | 0 | $1.39M | $2.55M | 0.98% | +$1.16M |
| CalciMedica, Inc.(CALC) | 521,114 | 521,114 | 0 | $2.06M | $2.31M | 0.88% | +$244.9K |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 2,834,910 | 0 | $7.65M | $1.70M | 0.65% | -$5.95M |
| Reneo Pharmaceuticals Inc (RPHM) | 886,075 | 886,075 | 0 | $1.34M | $1.51M | 0.58% | +$168.4K |
| Marker Therapeutics, Inc.(MRKR) | 314,286 | 314,286 | 0 | $1.71M | $886.3K | 0.34% | -$820.3K |
| Aclaris Therapeutics, Inc.(ACRS) | 434,455 | 434,455 | 0 | $477.9K | $499.6K | 0.19% | +$21.7K |
| Viracta Therapeutics Inc (VIRX) | 288,571 | 288,571 | 0 | $156.9K | $66.4K | 0.03% | -$90.5K |